SciELO - Scientific Electronic Library Online

 
vol.29 número3Confirmación de casos de rickettsiosis del grupo de las fiebres manchadas y del grupo del tifo mediante una vigilancia centinela de tres meses en el hospital para síndrome febril agudo indiferenciado en el municipio de Santander de Quilichao, Cauca, ColombiaDiagnóstico incidental de tuberculosis pulmonar en pacientes remitidos para broncoscopia diagnóstica o seguimiento clínico por enfermedad tumoral maligna: un estudio transversal índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Infectio

versión impresa ISSN 0123-9392

Resumen

PELAEZ-MARTINEZ, Juan David et al. Screening and Distribution of High-Risk HPV Genotypes in Women from Cali, Colombia in 2023: Results from the Por Ti Mujer Program. Infect. [online]. 2025, vol.29, n.3, pp.150-158.  Epub 10-Sep-2025. ISSN 0123-9392.  https://doi.org/10.22354/24223794.1236.

Introduction:

Persistent high-risk human papillomavirus (HPV) infections are strongly associated with cervical cancer, the leading cause of cancer-related deaths among women aged 30-59 years in Colombia. This study presents the screening results and distribution of high-risk HPV genotypes in women enrolled in the Por Ti Mujer programme in Cali, Colombia.

Materials and Methods:

A cross-sectional descriptive observational study was conducted using medical records of adult women screened using conventional cytology, high-risk HPV DNA testing, and visual inspection with acetic acid and lugol's iodine. Data were collected between January and June 2023 using the Por Ti Mujer program.

Results:

A total of 15,130 records were analyzed. Overall positivity, regardless of screening method, was 10.2%; positivity for HPV DNA was 15.2%, and positivity for cytology was 5.4%. Women aged 30-65 years and those in the contributory health insurance scheme group had higher rates of abnormal results. The most frequent high-risk HPV genotypes were 56-59-66 (21.2%), 33-39-68 (17.0%), 16 (13.8%), 33-58 (12.1%), and 52 (11.1%).

Discussion:

The HPV DNA positivity rate in the Por Ti Mujer program (15.2%) was higher than the global average (10.4%), but lower than the regional Latin American estimate (16.1%). The most prevalent genotypes were 56-59-66 and 33-39-68.

Palabras clave : Papillomavirus infection; mass screening; genotype; cervical cancer; cytology.

        · resumen en Español     · texto en Español     · Español ( pdf )